Use of Letermovir as Secondary Prophylaxis in Cardiac Transplant Patient, Mismatch for CMV (d plus /r-), Resistant to Ganciclovir and Foscarnet

被引：0
|
作者：
Sangani, A. [1 ]
Campanini, G. [2 ]
Puci, F. [1 ]
Truffelli, F. [1 ]
Lerta, S. [1 ]
Bruno, R. [3 ]
Seminari, E. [1 ]
机构：
[1] Fdn IRCSS Policlin San Matteo, Div Infect Dis 1, Pavia, Italy
[2] Fdn IRCSS Policlin San Matteo, Microbiol & Virol Unit, Pavia, Italy
[3] Univ Pavia, Dept Med Surg Diagnost & Pediat Sci, Pavia, Italy
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
968
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [1] Impact of Prolonging CMV Prophylaxis in High Risk (CMV D plus /R-) Lung Transplant Recipients
    Khan, B.
    Husain, S.
    Binnie, M.
    Chow, C.
    Martinu, T.
    Chaparro, C.
    Keshavjee, S.
    Singer, L. G.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S319 - S319
  • [2] Letermovir for Secondary Cytomegalovirus (CMV) Prophylaxis in a Pediatric Stem Cell Transplant Patient
    Le, Jennifer
    Zembillas, Anthony
    Stanton, Michael
    Dahl, Elizabeth
    Hanna, Rabi
    Flagg, Aron
    Rivard, Kaitlyn
    Gonzalez, Blanca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] Impact of Prolonging CMV Prophylaxis in High-Risk (CMV D plus /R-) Lung Transplant Recipients
    Herrera, S.
    Khan, B.
    Husain, S.
    Binnie, M.
    Chow, C.
    Martinu, T.
    Chaparro, C.
    Keshavjee, S.
    Singer, L. G.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S120 - S120
  • [4] Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients
    Rho, Elena
    Naef, Bettina
    Mueller, Thomas F.
    Wuethrich, Rudolf P.
    Schachter, Thomas
    von Moos, Seraina
    CLINICAL TRANSPLANTATION, 2021, 35 (11)
  • [5] Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients.
    Pereira, M. R.
    Aaron, J. G.
    Kubin, C. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 459 - 460
  • [6] Effect of Prophylaxis Duration on the Incidence of CMV Viremia and Hospitalization Rates in D plus /R- Kidney Transplant Recipients
    Sia, J.
    Westervelt, J.
    Lyden, E.
    Miles, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 211 - 212
  • [7] SUCCESSFUL USE OF LETERMOVIR IN SECONDARY CYTOMEGALOVIRUS PROPHYLAXIS IN A HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT AFFECTED BY GANCICLOVIR RESISTANT CYTOMEGALOVIRUS REACTIVATION.
    Stella, R.
    Sperotto, A.
    Rosignoli, C.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2020, 105 : S109 - S109
  • [8] Combining Letermovir with Valganciclovir May Allow an Early Switch From Foscarnet Among Kidney-Transplant-Recipients With Ganciclovir-resistant CMV Infection
    Rho, Elena
    Naef, Bettina
    Wuthrich, Rudolf
    Mueller, Thomas
    Schachtner, Thomas
    Von Moos, Seraina
    SWISS MEDICAL WEEKLY, 2020, : 19S - 19S
  • [9] A Novel Cytomegalovirus Prophylaxis Protocol in Cytomegalovirus (CMV) D plus /R- Heart Transplant Recipients: A Single-Center Experience
    Singh, Rajeev
    Rao, Krishnasree K.
    Garg, Sonia
    Amin, Alpesh A.
    Grodin, Justin L.
    Morlend, Robert
    Araj, Faris
    Thibodeau, Jennifer T.
    Mammen, Pradeep P. A.
    Peltz, Matthias
    Drazner, Mark H.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S126 - S126
  • [10] FAVORABLE OUTCOME OF LATE- ONSET CMV DISEASE IN D plus R- KIDNEY TRANSPLANT RECIPIENTS TREATED WITH UNIVERSAL PROPHYLAXIS
    Kaminski, H.
    Garrigue, I.
    Couzi, L.
    Moreau, J. F.
    Dechanet-Merville, J.
    Merville, P.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 11 - 11
12345